Clinical evidence for oral antiplatelet therapy in acute coronary syndromes

Lancet
Stephen D Wiviott, Philippe Gabriel Steg

Abstract

Platelet-mediated thrombosis is a major pathophysiological mechanism that underlies acute coronary syndromes, and therefore, antiplatelet therapy is an important foundation in the treatment and prevention of recurrence of these syndromes. Nearly 30 years ago, aspirin was the first agent to show a benefit for acute coronary syndromes and is still a key therapeutic agent. The landmark CURE trial showed that the addition of a P2Y12 antagonist, clopidogrel, to aspirin was beneficial in the treatment of acute coronary syndromes. Despite substantial benefits with clopidogrel, limitations include the slow speed of onset, variable response, and a modest antiplatelet effect. Next-generation P2Y12 antagonists, prasugrel and ticagrelor, overcome these limitations and have been shown, in large-scale clinical trials for acute coronary syndromes, to reduce ischaemic events more than clopidogrel, at the expense of an increase in bleeding. Additional agents that target platelets by alternate mechanisms, including the protease-activated receptor-1 antagonist vorapaxar, have shown ischaemic benefit. These large-scale trials inform treatment decisions that need to balance ischaemic benefit and bleeding risk in patients with acute coronary syndrom...Continue Reading

References

Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
Jan 18, 2005·Journal of the American College of Cardiology·Victor L SerebruanyEric J Topol
Feb 8, 2005·The American Journal of Cardiology·Stéphane SilbermanPhilippe Gabriel Steg
Nov 8, 2005·Lancet·Z M ChenUNKNOWN COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group
May 15, 2007·Journal of the American College of Cardiology·Deepak L BhattUNKNOWN CHARISMA Investigators
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Dec 25, 2008·The New England Journal of Medicine·Tabassome SimonUNKNOWN French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators
Apr 14, 2009·Current Atherosclerosis Reports·Ali J Marian
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Jan 19, 2010·Lancet·Christopher P CannonUNKNOWN PLATelet inhibition and patient Outcomes Investigators
Dec 2, 2010·Critical Pathways in Cardiology·Annemarie M Armani
Mar 17, 2011·JAMA : the Journal of the American Medical Association·Matthew J PriceUNKNOWN GRAVITAS Investigators
Nov 15, 2011·The New England Journal of Medicine·Pierluigi TricociUNKNOWN TRACER Investigators
Nov 18, 2011·JAMA : the Journal of the American Medical Association·Jessica L MegaMarc S Sabatine
Mar 27, 2012·The New England Journal of Medicine·David A MorrowUNKNOWN TRA 2P–TIMI 50 Steering Committee and Investigators
Aug 28, 2012·The New England Journal of Medicine·Matthew T RoeUNKNOWN TRILOGY ACS Investigators
Aug 28, 2012·European Heart Journal·UNKNOWN Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Doron Zahger
Nov 6, 2012·The New England Journal of Medicine·Jean-Philippe ColletUNKNOWN ARCTIC Investigators
Nov 22, 2012·Circulation. Cardiovascular Interventions·Dimitrios AlexopoulosGeorge Hahalis
Mar 12, 2013·The New England Journal of Medicine·Deepak L BhattUNKNOWN CHAMPION PHOENIX Investigators
Jun 12, 2013·Journal of the American College of Cardiology·Morten LambertsMorten Lock Hansen
Sep 3, 2013·The New England Journal of Medicine·Gilles MontalescotUNKNOWN ACCOAST Investigators

❮ Previous
Next ❯

Citations

Dec 15, 2015·Journal of Thrombosis and Thrombolysis·Pancras C WongEarl J Crain
Mar 21, 2016·Vascular Pharmacology·Raffaele De Caterina, Shinya Goto
Mar 21, 2016·Indian Heart Journal·Rohit Bhatia, Vipin Ola
Apr 3, 2016·Clinical Medicine : Journal of the Royal College of Physicians of London·Jecko Thachil
Sep 16, 2015·Archives of Cardiovascular Diseases·Gregory Ducrocq, Philippe Gabriel Steg
Apr 12, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Philippe Gabriel Steg, Grégory Ducrocq
May 25, 2016·Expert Review of Cardiovascular Therapy·Kevin P BlidenPaul A Gurbel
Aug 25, 2016·Arquivos de neuro-psiquiatria·Renan DominguesCarlos Senne
Jun 8, 2017·Journal of Cardiovascular Pharmacology and Therapeutics·Wilson Kwong, John D Parker
Dec 23, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Simon J WilsonDavid E Newby
Apr 2, 2016·Circulation Research·Clarice GareriCiro Indolfi
Jun 7, 2019·Nature Reviews. Disease Primers·Birgit VogelRoxana Mehran
Jan 14, 2017·Blood·Zoltan Nagy, Yotis A Senis
May 18, 2016·European Heart Journal·Christoph K NaberUNKNOWN LEADERS FREE Investigators
Jun 6, 2018·European Heart Journal Supplements : Journal of the European Society of Cardiology·Michele Massimo GuliziaUNKNOWN Faculty for approval of the Consensus Document
Sep 3, 2020·The Korean Journal of Internal Medicine·Sehun KimJung Rae Cho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Journal of Cardiovascular Translational Research
Flavio de Souza Brito, Pierluigi Tricoci
Nature Reviews. Cardiology
Francesco Franchi, Dominick J Angiolillo
© 2021 Meta ULC. All rights reserved